Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP868262.RAOKMbftIgrxP3ppvtnWVo-aHXEZEsucikeXjZs6clwro130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP868262.RAOKMbftIgrxP3ppvtnWVo-aHXEZEsucikeXjZs6clwro130_assertion type Assertion NP868262.RAOKMbftIgrxP3ppvtnWVo-aHXEZEsucikeXjZs6clwro130_head.
- NP868262.RAOKMbftIgrxP3ppvtnWVo-aHXEZEsucikeXjZs6clwro130_assertion description "[Evaluation of TRY1 and TRY2 mRNA expression by multiplex RT-PCR in a series of 20 colon tumor tissues representative of the range of tumor progression showed that TRY2 mRNA was expressed much more commonly than TRY1 mRNA in normal mucosa (26% vs. 6%) as well as in primary tumor tissues (65% vs. 15%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP868262.RAOKMbftIgrxP3ppvtnWVo-aHXEZEsucikeXjZs6clwro130_provenance.
- NP868262.RAOKMbftIgrxP3ppvtnWVo-aHXEZEsucikeXjZs6clwro130_assertion evidence source_evidence_literature NP868262.RAOKMbftIgrxP3ppvtnWVo-aHXEZEsucikeXjZs6clwro130_provenance.
- NP868262.RAOKMbftIgrxP3ppvtnWVo-aHXEZEsucikeXjZs6clwro130_assertion SIO_000772 11391623 NP868262.RAOKMbftIgrxP3ppvtnWVo-aHXEZEsucikeXjZs6clwro130_provenance.
- NP868262.RAOKMbftIgrxP3ppvtnWVo-aHXEZEsucikeXjZs6clwro130_assertion wasDerivedFrom befree-20140225 NP868262.RAOKMbftIgrxP3ppvtnWVo-aHXEZEsucikeXjZs6clwro130_provenance.
- NP868262.RAOKMbftIgrxP3ppvtnWVo-aHXEZEsucikeXjZs6clwro130_assertion wasGeneratedBy ECO_0000203 NP868262.RAOKMbftIgrxP3ppvtnWVo-aHXEZEsucikeXjZs6clwro130_provenance.